疏风解毒胶囊联合抗生素对老年急性细菌性上呼吸道感染疗效和血清炎症因子的影响
尹照萍,孙帅,刘国峰
摘要(Abstract):
目的 观察疏风解毒胶囊联合抗生素对老年急性细菌性上呼吸道感染疗效和血清炎症因子影响。方法患者186例随机等分为对照组(采用抗生素治疗)与观察组(采用抗生素+疏风解毒胶囊治疗)。记录两组炎症反应指标、细菌清除率及临床疗效。结果 观察组治疗后体温及白细胞计数均低于对照组(P <0.05);观察组治疗后的白细胞介素-1(IL-1)、白细胞介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)水平均低于对照组(P <0.05);观察组治疗后C反应蛋白(CRP)及降钙素原(PCT)水平均低于对照组(P <0.05);观察组细菌清除率为96.77%,高于对照组的84.95%(P <0.05);观察组治疗总有效率为91.40%,高于对照组的77.42%(P <0.05)。结论 疏风解毒胶囊联合抗生素治疗老年急性细菌性上呼吸道感染有助于降低血清炎症因子水平,提高细菌清除率,有效控制体温及炎症反应,疗效确切。
关键词(KeyWords): 急性上呼吸道感染;老年;疏风解毒胶囊;抗生素;炎症因子
基金项目(Foundation):
作者(Author): 尹照萍,孙帅,刘国峰
参考文献(References):
- [1] Stolz D,Papakonstantinou E,Grize L,et al. Time-course of upper respiratory tract viral infection and COPD exacerbation[J]. Eur Respir J,2019,54(4):1900407.
- [2] Azoulay E,Russell L,Van de Louw A,et al. Diagnosis of severe respiratory infections in immunocompromised patients[J]. Intensive Care Med,2020,46(2):298-314.
- [3] Ji S,Bai Q,Wu X,et al. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease[J]. Biomed Pharmacother,2020,121:109652.
- [4] Velkov T,Abdul Rahim N,Zhou QT,et al. Inhaled anti-infective chemotherapy for respiratory tract infections:successes,challenges and the road ahead[J]. Adv Drug Deliv Rev,2015,85:65-82.
- [5] Nam HH,Ison MG. Respiratory syncytial virus infection in adults[J]. BMJ,2019,366:15021.
- [6]王雷,邱晓梅.疏风解毒胶囊对急性上呼吸道感染患者伴发热的临床疗效评价[J].抗感染药学,2018,15(8):1406-1408.
- [7]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.急性上呼吸道感染基层诊疗指南(2018年)[J].中华全科医师杂志,2019,4(5):422-426.
- [8]余学庆,谢洋,李建生.社区获得性肺炎中医诊疗指南(2018修订版)[J].中医杂志,2019,60(4):350-360.
- [9]王俊.替考拉宁与万古霉素治疗革兰阳性菌感染的细菌清除率及不良反应比较[J].中国合理用药探索,2019,16(5):143-145.
- [10]奚肇庆,余婉蓉,刘清泉,等.外感发热(上呼吸道感染、流行性感冒)诊疗方案[J].中国中医急症,2013,22(4):519-520.
- [11] Zhang L,Forst CV,Gordon A,et al. Characterization of antibiotic resistance and host-microbiome interactions in the human upper respiratory tract during influenza infection[J]. Microbiome,2020,8(1):39.
- [12] Qin H,Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome:from basic to clinics[J]. Protein Cell,2020,11(10):707-722.
- [13]刘静,马莉,陆洁,等.疏风解毒胶囊解热作用机制研究[J].中草药,2016,47(12):2040-2043.
- [14]张铁军,朱月信,刘岱琳,等.疏风解毒胶囊药效物质基础及作用机制研究[J].中草药,2016,47(12):2019-2026.
- [15]贺丹.疏风解毒胶囊对成人流行性感冒患者临床症状的改善效果及安全性分析[J].中华中医药杂志,2021,36(5):3059-3061.
- [16]刘志群,王国茗,潘巍巍,等.疏风解毒胶囊治疗病毒性上呼吸道感染临床观察[J].中国中医急症,2020,29(5):898-900.
- [17] Dinarello CA. The IL-1 family of cytokines and receptors in rheumatic diseases[J]. Nat Rev Rheumatol,2019,15(10):612-632.
- [18] Giavridis T,van der Stegen SJC,Eyquem J,et al. CAR T cellinduced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade[J]. Nat Med,2018,24(6):731-738.
- [19] Mantovani A,Dinarello CA,Molgora M,et al. Interleukin-1and related cytokines in the regulation of inflammation and immunity[J]. Immunity,2019,50(4):778-795.
- [20] Moorlag SJCFM,R?ring RJ,Joosten LAB,et al. The role of the interleukin-1 family in trained immunity[J]. Immunol Rev,2018,281(1):28-39.